Exploring the potential role of catheter ablation in patients with asymptomatic atrial fibrillation should we move away from symptom relief?

Giovanni B. Forleo, Luigi Di Biase, Domenico G. Della Rocca, Gaetano Fassini, Luca Santini, Andrea Natale, Claudio Tondo

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Although silent atrial fibrillation (AF) accounts for a significant proportion of patients with AF, asymptomatic patients have been excluded from AF ablation trials. This population presents unique challenges to disease management. Recent evidence suggests that patients with asymptomatic AF may have a different risk profile and even worse long-term outcomes compared to patients with symptomatic AF. For the same reasons they might be more prone to side-effects of antiarrhythmic drugs, including pro-arrhythmias. The poor correlation between symptoms and AF demonstrated in several studies should caution physicians against making clinical decisions depending on symptoms. Although current guidelines recommend AF ablation only in patients with symptoms, more attention should be paid to the AF burden and a rhythm control strategy has the potential to improve morbidity and mortality in AF patients. However, limited data exist regarding the use of catheter ablation for asymptomatic AF patients. As ablation techniques have improved, AF ablation has become more widespread and complication rate decreased. As a result, referrals of asymptomatic patients for catheter ablation of AF are on the rise. In this review we discuss the many unresolved questions concerning the role of the ablative approach in asymptomatic patients with AF.

Original languageEnglish (US)
Pages (from-to)53-61
Number of pages9
JournalJournal of Atrial Fibrillation
Volume6
Issue number3
StatePublished - Oct 2013
Externally publishedYes

Fingerprint

Catheter Ablation
Atrial Fibrillation
Ablation Techniques
Anti-Arrhythmia Agents
Disease Management
Drug-Related Side Effects and Adverse Reactions
Cardiac Arrhythmias
Referral and Consultation

Keywords

  • Asymptomatic patients
  • Atrial fibrillation
  • Catheter ablation
  • Silent atrial fibrillation

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Exploring the potential role of catheter ablation in patients with asymptomatic atrial fibrillation should we move away from symptom relief? / Forleo, Giovanni B.; Di Biase, Luigi; Della Rocca, Domenico G.; Fassini, Gaetano; Santini, Luca; Natale, Andrea; Tondo, Claudio.

In: Journal of Atrial Fibrillation, Vol. 6, No. 3, 10.2013, p. 53-61.

Research output: Contribution to journalArticle

Forleo, Giovanni B. ; Di Biase, Luigi ; Della Rocca, Domenico G. ; Fassini, Gaetano ; Santini, Luca ; Natale, Andrea ; Tondo, Claudio. / Exploring the potential role of catheter ablation in patients with asymptomatic atrial fibrillation should we move away from symptom relief?. In: Journal of Atrial Fibrillation. 2013 ; Vol. 6, No. 3. pp. 53-61.
@article{18d107ca5bbf4129bec6b51940547a76,
title = "Exploring the potential role of catheter ablation in patients with asymptomatic atrial fibrillation should we move away from symptom relief?",
abstract = "Although silent atrial fibrillation (AF) accounts for a significant proportion of patients with AF, asymptomatic patients have been excluded from AF ablation trials. This population presents unique challenges to disease management. Recent evidence suggests that patients with asymptomatic AF may have a different risk profile and even worse long-term outcomes compared to patients with symptomatic AF. For the same reasons they might be more prone to side-effects of antiarrhythmic drugs, including pro-arrhythmias. The poor correlation between symptoms and AF demonstrated in several studies should caution physicians against making clinical decisions depending on symptoms. Although current guidelines recommend AF ablation only in patients with symptoms, more attention should be paid to the AF burden and a rhythm control strategy has the potential to improve morbidity and mortality in AF patients. However, limited data exist regarding the use of catheter ablation for asymptomatic AF patients. As ablation techniques have improved, AF ablation has become more widespread and complication rate decreased. As a result, referrals of asymptomatic patients for catheter ablation of AF are on the rise. In this review we discuss the many unresolved questions concerning the role of the ablative approach in asymptomatic patients with AF.",
keywords = "Asymptomatic patients, Atrial fibrillation, Catheter ablation, Silent atrial fibrillation",
author = "Forleo, {Giovanni B.} and {Di Biase}, Luigi and {Della Rocca}, {Domenico G.} and Gaetano Fassini and Luca Santini and Andrea Natale and Claudio Tondo",
year = "2013",
month = "10",
language = "English (US)",
volume = "6",
pages = "53--61",
journal = "Journal of Atrial Fibrillation",
issn = "1941-6911",
publisher = "Cardiofront, Inc.",
number = "3",

}

TY - JOUR

T1 - Exploring the potential role of catheter ablation in patients with asymptomatic atrial fibrillation should we move away from symptom relief?

AU - Forleo, Giovanni B.

AU - Di Biase, Luigi

AU - Della Rocca, Domenico G.

AU - Fassini, Gaetano

AU - Santini, Luca

AU - Natale, Andrea

AU - Tondo, Claudio

PY - 2013/10

Y1 - 2013/10

N2 - Although silent atrial fibrillation (AF) accounts for a significant proportion of patients with AF, asymptomatic patients have been excluded from AF ablation trials. This population presents unique challenges to disease management. Recent evidence suggests that patients with asymptomatic AF may have a different risk profile and even worse long-term outcomes compared to patients with symptomatic AF. For the same reasons they might be more prone to side-effects of antiarrhythmic drugs, including pro-arrhythmias. The poor correlation between symptoms and AF demonstrated in several studies should caution physicians against making clinical decisions depending on symptoms. Although current guidelines recommend AF ablation only in patients with symptoms, more attention should be paid to the AF burden and a rhythm control strategy has the potential to improve morbidity and mortality in AF patients. However, limited data exist regarding the use of catheter ablation for asymptomatic AF patients. As ablation techniques have improved, AF ablation has become more widespread and complication rate decreased. As a result, referrals of asymptomatic patients for catheter ablation of AF are on the rise. In this review we discuss the many unresolved questions concerning the role of the ablative approach in asymptomatic patients with AF.

AB - Although silent atrial fibrillation (AF) accounts for a significant proportion of patients with AF, asymptomatic patients have been excluded from AF ablation trials. This population presents unique challenges to disease management. Recent evidence suggests that patients with asymptomatic AF may have a different risk profile and even worse long-term outcomes compared to patients with symptomatic AF. For the same reasons they might be more prone to side-effects of antiarrhythmic drugs, including pro-arrhythmias. The poor correlation between symptoms and AF demonstrated in several studies should caution physicians against making clinical decisions depending on symptoms. Although current guidelines recommend AF ablation only in patients with symptoms, more attention should be paid to the AF burden and a rhythm control strategy has the potential to improve morbidity and mortality in AF patients. However, limited data exist regarding the use of catheter ablation for asymptomatic AF patients. As ablation techniques have improved, AF ablation has become more widespread and complication rate decreased. As a result, referrals of asymptomatic patients for catheter ablation of AF are on the rise. In this review we discuss the many unresolved questions concerning the role of the ablative approach in asymptomatic patients with AF.

KW - Asymptomatic patients

KW - Atrial fibrillation

KW - Catheter ablation

KW - Silent atrial fibrillation

UR - http://www.scopus.com/inward/record.url?scp=84892900785&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84892900785&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:84892900785

VL - 6

SP - 53

EP - 61

JO - Journal of Atrial Fibrillation

JF - Journal of Atrial Fibrillation

SN - 1941-6911

IS - 3

ER -